Search

Your search keyword '"Pandey, Ambarish"' showing total 36 results
Start Over Author "Pandey, Ambarish" Publisher american medical association
36 results on '"Pandey, Ambarish"'

1. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.

Author

Jacobs, Joshua A., Addo, Daniel K., Zheutlin, Alexander R., Derington, Catherine G., Essien, Utibe R., Navar, Ann Marie, Hernandez, Inmaculada, Lloyd-Jones, Donald M., King, Jordan B., Rao, Shreya, Herrick, Jennifer S., Bress, Adam P., and Pandey, Ambarish

Published
2023
Full Text
View/download PDF

6. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.

Author

Berry, Jarett D., Nambi, Vijay, Ambrosius, Walter T., Chen, Haiying, Killeen, Anthony A., Taylor, Addison, Toto, Robert D., Soliman, Elsayed Z., McEvoy, John W., Pandey, Ambarish, Joshi, Parag H., Blankenberg, Stefan, Kitzman, Dalane W., Ballantyne, Christie M., and de Lemos, James A.

Published
2021
Full Text
View/download PDF

19. Searching for the Optimal Exercise Training Regimen in Heart Failure With Preserved Ejection Fraction.

Author

Pandey, Ambarish and Kitzman, Dalane W.

Abstract

The author comments on the results of the OptimEx-Clin study, published in the issue, which examined the role of exercise training in patients with heart failure with preserved ejection fraction. Topics covered include the lessons provided by the clinical trial, the factors attributed to the lack of greater efficacy of high-intensity interval training versus moderate continuous training and the approaches that could be considered to improve long-term adherence to exercise training.

Published
2021
Full Text
View/download PDF

22. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines

Author

Pandey, Ambarish, Golwala, Harsh, Hall, Hurst M., Wang, Tracy Y., Di Lu, Ying Xian, Chiswell, Karen, Joynt, Karen E., Goyal, Abhinav, Das, Sandeep R., Kumbhani, Dharam, Julien, Howard, Fonarow, Gregg C., and de Lemos, James A.

Published
2017
Full Text
View/download PDF

27. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.

Author

Khera, Rohan, Pandey, Ambarish, Ayers, Colby R., Carnethon, Mercedes R., Greenland, Philip, Ndumele, Chiadi E, Nambi, Vijay, Seliger, Stephen L., Chaves, Paulo H. M., Safford, Monika M., Cushman, Mary, Xanthakis, Vanessa, Ramachandran, Vasan S., Mentz, Robert J., Correa, Adolfo, Lloyd-Jones, Donald M., Berry, Jarett D., de Lemos, James A., and Neeland, Ian J.

Published
2020
Full Text
View/download PDF

31. β-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets.

Author

Gupta, Arjun, Das, Sandeep R., and Pandey, Ambarish

Abstract

This JAMA Performance Improvement article uses the case of a patient with acute myocardial infarction and heart failure who developed cardiogenic shock after being given carvedilol as part of a standard STEMI admission order set to discuss the limits of orders sets and of guideline-based care and the need to optimize each for individual patient circumstances. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

35. Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs.

Author

Polsinelli VB, Sun JL, Greene SJ, Chiswell K, Grunwald GK, Allen LA, Peterson P, Pandey A, Fonarow GC, Heidenreich P, Ho PM, and Hess PL

Abstract

Importance: A composite score for guideline-directed medical therapy (GDMT) for patients with heart failure (HF) is associated with increased survival. Whether hospital performance according to a GDMT score is associated with a broader array of clinical outcomes at lower costs is unknown., Objectives: To evaluate hospital variability in GDMT score at discharge, 90-day risk-standardized clinical outcomes and costs, and associations between hospital GDMT score and clinical outcomes and costs., Design, Setting, and Participants: This was a retrospective cohort study conducted from January 2015 to September 2019. Included for analysis were patients hospitalized for HF with reduced ejection fraction (HFrEF) in the Get With the Guidelines-Heart Failure Registry, a national hospital-based quality improvement registry. Study data were analyzed from July 2022 to April 2023., Exposures: GDMT score at discharge., Main Outcomes and Measures: Hospital variability in GDMT score, a weighted index from 0 to 1 of GDMT prescribed divided by the number of medications eligible, at discharge was evaluated using a generalized linear mixed model using the hospital as a random effect and quantified with the adjusted median odds ratio (AMOR). Parallel analyses centering on 90-day mortality, HF rehospitalization, mortality or HF rehospitalization, home time, and costs were performed. Costs were assessed from the perspective of the Centers of Medicare & Medicaid Services. Associations between hospital GDMT score and clinical outcomes and costs were evaluated using Spearman coefficients., Results: Among 41 161 patients (median [IQR] age, 78 [71-85] years; 25 546 male [62.1%]) across 360 hospitals, there was significant hospital variability in GDMT score at discharge (AMOR, 1.23; 95% CI, 1.21-1.26), clinical outcomes (mortality AMOR, 1.17; 95% CI, 1.14-1.24; HF rehospitalization AMOR, 1.22; 95% CI, 1.18-1.27; mortality or HF rehospitalization AMOR, 1.21; 95% CI, 1.18-1.26; home time AMOR, 1.07; 95% CI, 1.06-1.10) and costs (AMOR, 1.23; 95% CI, 1.21-1.26). Higher hospital GDMT score was associated with lower hospital mortality (Spearman ρ, -0.22; 95% CI, -0.32 to -0.12; P < .001), lower mortality or HF rehospitalization (Spearman ρ, -0.17; 95% CI, -0.26 to -0.06; P = .002), more home time (Spearman ρ, 0.14; 95% CI, 0.03-0.24; P = .01), and lower cost (Spearman ρ, -0.11; 95% CI, -0.21 to 0; P = .047) but not with HF rehospitalization (Spearman ρ, -0.10; 95% CI, -0.20 to 0; P = .06)., Conclusions and Relevance: Results of this cohort study reveal that hospital variability in GDMT score, clinical outcomes, and costs was significant. Higher GDMT score at discharge was associated with lower mortality, lower mortality or hospitalization, more home time, and lower cost. Efforts to increase health care value should include GDMT optimization.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results